<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:ifp="http://www.ifactory.com/press" ifp-element-xpath="/*[local-name() = 'urlset' and namespace-uri() = 'http://www.sitemaps.org/schemas/sitemap/0.9']"><ifp:contentType>ARTICLE</ifp:contentType><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/7/Suppl_7/article-pS-1.xml</sm:loc><ifp:title>The Science and Practice of Bone Health in Oncology: Managing Bone Loss and Metastasis in Patients With Solid Tumors</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/7/Suppl_7/article-pS-1.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>The Science and Practice of Bone Health in Oncology: Managing Bone Loss and Metastasis in Patients With Solid Tumors</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/7/9/article-p947.xml</sm:loc><ifp:title>Novel Therapies in the Treatment of Multiple Myeloma</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/7/9/article-p947.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Novel Therapies in the Treatment of Multiple Myeloma</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/7/9/article-p908.xml</sm:loc><ifp:title>Multiple Myeloma</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/7/9/article-p908.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Multiple Myeloma</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/7/9/article-p905.xml</sm:loc><ifp:title>What is a Patient Navigator, and Should We Have Them in Major Cancer Centers?</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/7/9/article-p905.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>What is a Patient Navigator, and Should We Have Them in Major Cancer Centers?</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/7/9/article-p971.xml</sm:loc><ifp:title>Supportive Therapies in Multiple Myeloma</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/7/9/article-p971.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Supportive Therapies in Multiple Myeloma</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/7/9/article-p961.xml</sm:loc><ifp:title>Hematopoietic Stem Cell Transplantation in Multiple Myeloma</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/7/9/article-p961.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Hematopoietic Stem Cell Transplantation in Multiple Myeloma</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/7/9/article-p1028.xml</sm:loc><ifp:title>New Agents in the Treatment of Chronic Myelogenous Leukemia</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/7/9/article-p1028.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>New Agents in the Treatment of Chronic Myelogenous Leukemia</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/7/9/article-p984.xml</sm:loc><ifp:title>Chronic Myelogenous Leukemia</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/7/9/article-p984.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Chronic Myelogenous Leukemia</ifp:title></sm:url></urlset>
